Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,405 | -9,327 | -6,017 | -1,874 | -8,123 |
| Depreciation Amortization | 44 | 29 | 18 | 8 | 129 |
| Accounts payable and accrued liabilities | 18 | 216 | -144 | -167 | 81 |
| Other Working Capital | -64 | -127 | -172 | -736 | -340 |
| Other Operating Activity | 2,445 | 2,691 | 2,095 | 382 | 1,659 |
| Operating Cash Flow | $-8,962 | $-6,518 | $-4,220 | $-2,387 | $-6,594 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -111 | -54 | -52 | -51 | N/A |
| Investing Cash Flow | $-111 | $-54 | $-52 | $-51 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 6,912 |
| Other Financing Activity | 12,291 | 12,291 | 12,291 | 0 | 3,872 |
| Financing Cash Flow | $12,291 | $12,291 | $12,291 | $N/A | $10,784 |
| Beginning Cash Position | 7,273 | 7,273 | 7,273 | 7,273 | 3,083 |
| End Cash Position | 10,491 | 12,991 | 15,292 | 4,835 | 7,273 |
| Net Cash Flow | $3,218 | $5,718 | $8,019 | $-2,438 | $4,190 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,962 | -6,518 | -4,220 | -2,387 | -6,594 |
| Capital Expenditure | -111 | -54 | -52 | -51 | N/A |
| Free Cash Flow | -9,073 | -6,572 | -4,271 | -2,438 | -6,594 |